• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估偏头痛影响的患者报告结局指标——偏头痛身体功能影响日记(MPFID)的内容效度的开发与探索。

Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).

作者信息

Hareendran Asha, Mannix Sally, Skalicky Anne, Bayliss Martha, Blumenfeld Andrew, Buse Dawn C, Desai Pooja R, Ortmeier Brian G, Sapra Sandhya

机构信息

Evidera, Metro Building, 6th Floor, 1 Butterwick, London, W6 8DL, UK.

Evidera, Bethesda, MD, USA.

出版信息

Health Qual Life Outcomes. 2017 Nov 17;15(1):224. doi: 10.1186/s12955-017-0799-1.

DOI:10.1186/s12955-017-0799-1
PMID:29149901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5693572/
Abstract

BACKGROUND

Adults with migraine experience substantial reductions in quality of life during and in-between migraine attacks. Clinical and regulatory guidelines encourage the inclusion of patient reported outcomes for the evaluation of benefits of interventions for migraine.

METHODS

The conceptual framework and items for a new patient-reported outcome (PRO) instrument, the Migraine Physical Function Impact Diary (MPFID), were developed using scientific methods recommended to ensure content validity of PRO instruments. The MPFID was developed to measure the impact of migraine on physical functioning based on themes raised in concept elicitation (CE) interviews (conducted previously) with adults with migraine. Cognitive interviews were conducted with adults with migraine to further explore content validity. The instrument was modified following an interim analysis of a first round of cognitive interviews, to assess comprehensiveness and clarity of items, instructions, and response options. Refinements were subsequently tested in additional cognitive interviews.

RESULTS

The conceptual framework included impacts on physical functioning experienced by most adults with migraine and deemed clinically relevant for measuring the outcome of an intervention for migraine. Concepts in the framework included the impact of migraine on physical impairments (acts) and ability to complete day-to-day activities and perform everyday activities (tasks). MPFID items were generated to evaluate functioning over the past 24 h and to collect data daily, to capture experiences on days with migraine as well as the days in-between migraines. Items asked about needing to rest or lie down; ability to get out of bed, stand up, bend over, walk, perform household chores, do tasks outside the home, keep routines or schedules, get ready for the day, do activities that require concentration or clear thinking; difficulty moving head and body, doing activities requiring physical effort; avoiding interacting with others. Initial modifications based on the first round of cognitive interviews (n = 8) included clarifying instructions, updating three items to enhance specificity and clarity, and revising one item to include gender-neutral language. The second round of interviews (n = 9) confirmed acceptability of revisions and supported content validity.

CONCLUSIONS

The results provide qualitative evidence supporting the content validity of the MPFID for evaluating outcomes of interventions for migraine.

摘要

背景

偏头痛成年患者在偏头痛发作期间及发作间期生活质量大幅下降。临床和监管指南鼓励纳入患者报告结局,以评估偏头痛干预措施的疗效。

方法

采用推荐的科学方法开发了一种新的患者报告结局(PRO)工具——偏头痛身体功能影响日记(MPFID)的概念框架和条目,以确保PRO工具的内容效度。MPFID旨在根据之前对偏头痛成年患者进行的概念激发(CE)访谈中提出的主题,测量偏头痛对身体功能的影响。对偏头痛成年患者进行了认知访谈,以进一步探讨内容效度。在对第一轮认知访谈进行中期分析后,对该工具进行了修改,以评估条目的全面性和清晰度、说明及回答选项。随后在更多的认知访谈中对改进内容进行了测试。

结果

概念框架包括大多数偏头痛成年患者所经历的对身体功能的影响,且被认为在临床上与测量偏头痛干预措施的结局相关。框架中的概念包括偏头痛对身体损伤(行为)以及完成日常活动和执行日常任务(事务)能力的影响。MPFID条目旨在评估过去24小时内的功能,并每天收集数据,以捕捉偏头痛发作日以及发作间期的经历。条目询问了是否需要休息或躺下;起床、站立、弯腰、行走、做家务、外出做事、保持日常安排或时间表、为一天做好准备、进行需要集中注意力或清晰思考的活动的能力;头部和身体移动困难、进行需要体力的活动困难;避免与他人互动。基于第一轮认知访谈(n = 8)的初步修改包括澄清说明、更新三个条目以提高特异性和清晰度,以及修改一个条目以纳入中性语言。第二轮访谈(n = 9)确认了修改的可接受性,并支持内容效度。

结论

结果提供了定性证据,支持MPFID在评估偏头痛干预措施结局方面的内容效度。

相似文献

1
Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).用于评估偏头痛影响的患者报告结局指标——偏头痛身体功能影响日记(MPFID)的内容效度的开发与探索。
Health Qual Life Outcomes. 2017 Nov 17;15(1):224. doi: 10.1186/s12955-017-0799-1.
2
Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary.评估偏头痛对身体功能影响的新工具的心理计量学评价:偏头痛身体功能影响日记。
Headache. 2017 Oct;57(9):1385-1398. doi: 10.1111/head.13162. Epub 2017 Aug 30.
3
Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).开发一种新工具评估偏头痛预防性治疗对功能结局的获益 - 偏头痛功能影响问卷(MFIQ)。
Headache. 2018 Nov;58(10):1612-1628. doi: 10.1111/head.13420. Epub 2018 Oct 30.
4
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches.测量偏头痛的影响以评估偏头痛预防性治疗的效果。
Health Qual Life Outcomes. 2016 Oct 6;14(1):143. doi: 10.1186/s12955-016-0542-3.
5
Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.肺动脉高压-症状与影响(PAH-SYMPACT®)问卷的开发:一种新的肺动脉高压患者报告结局工具。
Respir Res. 2016 Jun 14;17(1):72. doi: 10.1186/s12931-016-0388-6.
6
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.开发和验证一种用于偶发性偏头痛和慢性偏头痛患者的新型患者报告结局测量工具:偏头痛活动障碍日记。
Headache. 2022 Jan;62(1):89-105. doi: 10.1111/head.14229. Epub 2021 Dec 28.
7
Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.非小细胞肺癌症状评估问卷(NSCLC-SAQ)的质性开发与内容效度:一项患者报告结局工具
Clin Ther. 2016 Apr;38(4):794-810. doi: 10.1016/j.clinthera.2016.03.012. Epub 2016 Apr 1.
8
Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ).评估偏头痛功能影响问卷(MFIQ)的心理计量特性。
Headache. 2019 Sep;59(8):1253-1269. doi: 10.1111/head.13569. Epub 2019 Jun 5.
9
The Severity of Chronic Cough Diary (SCCD): development and content validation of a novel patient-reported outcome instrument for evaluating the symptom experience of chronic cough.慢性咳嗽日记严重程度表(SCCD):一种评估慢性咳嗽症状体验的新型患者报告结局工具的开发和内容验证。
J Patient Rep Outcomes. 2023 Jul 10;7(1):65. doi: 10.1186/s41687-023-00605-8.
10
Evaluating functional outcomes in adolescents with attention-deficit/hyperactivity disorder: development and initial testing of a self-report instrument.评估注意力缺陷/多动障碍青少年的功能结局:一种自我报告工具的开发与初步测试
Health Qual Life Outcomes. 2015 Aug 22;13:133. doi: 10.1186/s12955-015-0302-9.

引用本文的文献

1
Understanding data visualization techniques in qualitative studies used to develop and validate patient-reported outcome measures: a targeted literature review.理解用于开发和验证患者报告结局指标的定性研究中的数据可视化技术:一项针对性文献综述。
Qual Life Res. 2025 Apr 25. doi: 10.1007/s11136-025-03964-5.
2
Unveiling the efficacy and safety of Erenumab, a monoclonal antibody targeting calcitonin gene-related peptide (CGRP) receptor, in patients with chronic and episodic migraine: a GRADE-assessed systematic review and meta-analysis of randomized clinical trials with subgroup analysis.揭示靶向降钙素基因相关肽(CGRP)受体的单克隆抗体erenumab在慢性和发作性偏头痛患者中的疗效和安全性:一项GRADE评估的随机临床试验系统评价和荟萃分析及亚组分析
Head Face Med. 2025 Mar 26;21(1):19. doi: 10.1186/s13005-025-00494-w.
3

本文引用的文献

1
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches.测量偏头痛的影响以评估偏头痛预防性治疗的效果。
Health Qual Life Outcomes. 2016 Oct 6;14(1):143. doi: 10.1186/s12955-016-0542-3.
2
The International Classification of Headache Disorders, 3rd edition (beta version).《国际头痛疾病分类》第三版(试用版)
Cephalalgia. 2013 Jul;33(9):629-808. doi: 10.1177/0333102413485658.
3
Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine.偏头痛对功能的影响:两项偏头痛患者生活质量定性研究的结果。
Headache. 2024 Feb;64(2):156-171. doi: 10.1111/head.14664. Epub 2024 Jan 18.
4
Zavegepant nasal spray for the acute treatment of migraine: A meta analysis.依帕司他治疗糖尿病周围神经病变有效性和安全性的 Meta 分析。
Medicine (Baltimore). 2023 Oct 27;102(43):e35632. doi: 10.1097/MD.0000000000035632.
5
The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization.临床量表和患者报告结局量表在头痛疾病和偏头痛中的应用,总结其传播和实施情况。
Heliyon. 2023 May 13;9(5):e16187. doi: 10.1016/j.heliyon.2023.e16187. eCollection 2023 May.
6
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial.预防性偏头痛治疗用阿替利珠单抗对 ADVANCE 随机、双盲、3 期临床试验中患者报告结局的影响。
Neurology. 2023 Feb 21;100(8):e764-e777. doi: 10.1212/WNL.0000000000201568. Epub 2022 Nov 17.
7
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study.偏头痛发作间期负担和治疗的真实世界体验:一项定性访谈研究。
J Headache Pain. 2022 Jun 8;23(1):65. doi: 10.1186/s10194-022-01429-5.
8
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1 edition.国际头痛学会基于临床的头痛登记处指南,第 1 版。
Cephalalgia. 2022 Oct;42(11-12):1099-1115. doi: 10.1177/03331024221099035. Epub 2022 May 6.
9
The relevance of migraine in the clinical spectrum of mitochondrial disorders.偏头痛在线粒体疾病临床谱中的相关性。
Sci Rep. 2022 Mar 10;12(1):4222. doi: 10.1038/s41598-022-08206-z.
10
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.开发和验证一种用于偶发性偏头痛和慢性偏头痛患者的新型患者报告结局测量工具:偏头痛活动障碍日记。
Headache. 2022 Jan;62(1):89-105. doi: 10.1111/head.14229. Epub 2021 Dec 28.
慢性偏头痛和发作性偏头痛患者丧失生产时间的成本和预测因素:来自美国偏头痛患病率和预防(AMPP)研究的结果。
Value Health. 2013 Jan-Feb;16(1):31-8. doi: 10.1016/j.jval.2012.08.2212.
4
A systematic review of the psychosocial difficulties relevant to patients with migraine.偏头痛患者相关的心理社会困难的系统评价。
J Headache Pain. 2012 Nov;13(8):595-606. doi: 10.1007/s10194-012-0482-1. Epub 2012 Sep 23.
5
Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.基于证据的指南更新:非甾体抗炎药和其他补充治疗成人发作性偏头痛预防:美国神经病学学会和美国头痛学会质量标准小组委员会的报告。
Neurology. 2012 Apr 24;78(17):1346-53. doi: 10.1212/WNL.0b013e3182535d0c.
6
Why HURT? A review of clinical instruments for headache management.为何会痛?头痛管理的临床工具综述。
Curr Pain Headache Rep. 2012 Jun;16(3):237-54. doi: 10.1007/s11916-012-0263-1.
7
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.内容效度——在新开发的用于医疗产品评估的患者报告结局(PRO)工具中建立和报告证据:ISPOR PRO 良好研究实践工作组报告:第 2 部分——评估受访者的理解。
Value Health. 2011 Dec;14(8):978-88. doi: 10.1016/j.jval.2011.06.013. Epub 2011 Oct 10.
8
Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.慢性和阵发性偏头痛的头痛影响:来自美国偏头痛患病率和预防研究的结果。
Headache. 2012 Jan;52(1):3-17. doi: 10.1111/j.1526-4610.2011.02046.x. Epub 2011 Nov 22.
9
Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration.患者报告结局(PRO)测量的回顾期选择:考虑标准。
Qual Life Res. 2012 Aug;21(6):1013-20. doi: 10.1007/s11136-011-0003-8. Epub 2011 Sep 10.
10
Functioning and disability in migraine.偏头痛的功能障碍和残疾。
Disabil Rehabil. 2010;32 Suppl 1:S23-32. doi: 10.3109/09638288.2010.511687. Epub 2010 Sep 9.